Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

This study has been completed.

Study NCT00521001 Information provided by National Cancer Institute (NCI)

First Received: August 24, 2007 Last Updated: December 10, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)

Publications:

Dronca RS, Perez DG, Allred J, et al.: N0675: NCCTG phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma (MM). [Abstract] J Clin Oncol 28 (Suppl 15): A-8572, 2010.